Sutro Biopharma's Series D Round

Sutro Biopharma raised a round of funding on December 11, 2013.

Sutro Biopharma is a clinical stage drug discovery, development and manufacturing company focused on leveraging its integrated cell-free protein synthesis platform, XpressCF, to create a broad variety…

Articles about Sutro Biopharma's Series D Round: